Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4876 AL 4890

Amyloid β-interacting partners in Alzheimer's disease: From accomplices to possible therapeutic targets

Han SH, Park JC, Mook-Jung I.

Prog Neurobiol. 2016 Feb;137:17-38. doi: 10.1016/j.pneurobio.2015.12.004. Epub 2015 Dec 23.

Overview of Alzheimer's Disease and Some Therapeutic Approaches Targeting Aβ by Using Several Synthetic and Herbal Compounds

Singh SK, Srivastav S, Yadav AK, Srikrishna S, Perry G.

Oxid Med Cell Longev. 2016;2016:7361613. doi: 10.1155/2016/7361613. Epub 2015 Dec 28.

Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis

Wang J, Tan L, Wang HF, Tan CC, Meng XF, Wang C, Tang SW, Yu JT.

J Alzheimers Dis. 2015;44(2):385-96. doi: 10.3233/JAD-141506.

Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer's disease: a meta-analysis

Ye R, Hu Y, Yao A, Yang Y, Shi Y, Jiang Y, Zhang J.

Int J Clin Pract. 2015 Jun;69(6):674-81. doi: 10.1111/ijcp.12626. Epub 2015 Feb 27.

Hypothesis: glutaminyl cyclase inhibitors decrease risks of Alzheimer's disease and related dementias

Hennekens CH, Bensadon BA, Zivin R, Gaziano JM.

Expert Rev Neurother. 2015;15(11):1245-8. doi: 10.1586/14737175.2015.1088784. Epub 2015 Oct 8.

Higher Frequency and Complexity of Sleep Disturbances in Dementia with Lewy Bodies as Compared to Alzheimer's Disease

Chwiszczuk L, Breitve M, Hynninen M, Gjerstad MD, Aarsland D, Rongve A.

Neurodegener Dis. 2016;16(3-4):152-60. doi: 10.1159/000439252. Epub 2015 Nov 10.

Unlocking Electronic Medical Record Data to Identify Possible Connections Between Cancer and Cognitive Declines

McGinty HL.

J Clin Oncol. 2016 Feb 20;34(6):530-2. doi: 10.1200/JCO.2015.65.2248. Epub 2015 Dec 28.

Inflammatory hypothesis as a link between Alzheimer's disease and diabetes mellitus

Bozluolcay M, Andican G, Fırtına S, Erkol G, Konukoglu D.

Geriatr Gerontol Int. 2016 Oct;16(10):1161-1166. doi: 10.1111/ggi.12602. Epub 2015 Sep 3.

Cognitive and functional decline and their relationship in patients with mild Alzheimer's dementia

Liu-Seifert H, Siemers E, Sundell K, Price K, Han B, Selzler K, Aisen P, Cummings J, Raskin J, Mohs R.

J Alzheimers Dis. 2015;43(3):949-55. doi: 10.3233/JAD-140792.

Tolerability and safety of Souvenaid in patients with mild Alzheimer's disease: results of multi-center, 24-week, open-label extension study

Olde Rikkert MG, Verhey FR, Blesa R, von Arnim CA, Bongers A, Harrison J, Sijben J, Scarpini E, Vandewoude MF, Vellas B, Witkamp R, Kamphuis PJ, Scheltens P.

J Alzheimers Dis. 2015;44(2):471-80. doi: 10.3233/JAD-141305.

Trazodone and cognitive performance in Alzheimer disease

Camargos EF, Quintas JL, Louzada LL, Naves JO, Furioso AC, Nóbrega OT.

J Clin Psychopharmacol. 2015 Feb;35(1):88-9. doi: 10.1097/JCP.0000000000000237.

The impact of supplemental macular carotenoids in Alzheimer's disease: a randomized clinical trial

Nolan JM, Loskutova E, Howard A, Mulcahy R, Moran R, Stack J, Bolger M, Coen RF, Dennison J, Akuffo KO, Owens N, Power R, Thurnham D, Beatty S.

J Alzheimers Dis. 2015;44(4):1157-69. doi: 10.3233/JAD-142265.

Evaluating high-dose rivastigmine patch in severe Alzheimer's disease: analyses with concomitant memantine usage as a factor

Grossberg GT, Farlow MR, Meng X, Velting DM.

Curr Alzheimer Res. 2015;12(1):53-60. doi: 10.2174/1567205011666141218122835.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias